Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #31183
advertisement
Jiang H
13
Showing records 1 to 13 |
Display all abstracts from
Jiang H
99036
miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Xu L
Journal of Ophthalmology
2022; 2022: 3584192
98469
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Jiang H
Experimental Eye Research
2022; 217: 108910
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Fang F
Molecular Therapy
2022; 30: 1421-1431
99036
miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Zhang Y
Journal of Ophthalmology
2022; 2022: 3584192
98469
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Luo J
Experimental Eye Research
2022; 217: 108910
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Zhuang P; Feng X
Molecular Therapy
2022; 30: 1421-1431
99036
miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Long H
Journal of Ophthalmology
2022; 2022: 3584192
98469
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Lei H
Experimental Eye Research
2022; 217: 108910
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu P
Molecular Therapy
2022; 30: 1421-1431
99036
miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Zhou B
Journal of Ophthalmology
2022; 2022: 3584192
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu D
Molecular Therapy
2022; 30: 1421-1431
99036
miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Jiang H
Journal of Ophthalmology
2022; 2022: 3584192
98727
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Huang H; Li L; Chen W; Liu L; Sun Y; Jiang H; Ye J; Hu Y
Molecular Therapy
2022; 30: 1421-1431
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept